期刊文献+

二甲双胍单药及不同联合用药方案治疗2型糖尿病的比较研究 被引量:2

下载PDF
导出
摘要 目的探讨二甲双胍单药与不同联合用药方案治疗2型糖尿病的临床疗效的比较。方法选取该院75例2型糖尿病患者,将其分为A、B、C 3组,A组单用二甲双胍药物,B组采用二甲双胍联合门冬胰岛素与吡格列酮药物治疗,C组采用二甲双胍联合罗格列酮与诺和灵药物治疗。对比3组患者的疗效。结果 A组治疗总有效率为96%,B组总有效率为96%,C组总有效率为88%。组间治疗效果对比差异无统计学意义(P>0.05)。结论 2型糖尿病采用3组用药方案治疗均具有较为满意的疗效,但以药物经济学方面分析,A组的用药方案最为经济实用。
作者 孙克苏
出处 《糖尿病新世界》 2015年第2期26-26,共1页 Diabetes New World Magazine
  • 相关文献

参考文献3

二级参考文献28

  • 1吴伟华,张巾超,于江波,刘国良.2型糖尿病及合并大血管病变糖尿病患者C反应蛋白水平观察[J].中华内分泌代谢杂志,2003,19(4):257-259. 被引量:68
  • 2武桂新,严翊,冯炜权.壳聚糖对无氧训练大鼠糖代谢的影响[J].体育科学,2002,22(1):91-93. 被引量:9
  • 3Waugh N, Cummins E, Royle P, et al. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation [ J]. Health Technol Assess, 2010, 14(36) : 1.
  • 4VanDeKoppel S, Choe H M, Sweet B V. Managed care per- spective on three new agents for type 2 diabetes[J]. J Manag Care Pharm, 2008, 14(4) : 363.
  • 5Jadzinsky M, Pfutzner A, Paz-Pacheco E, et al. Saxagliptia given in combination with metformin as initial therapy im- proves glycaemic control in patients with type 2 diabetes com- pared with either monotherapy: a randomized controlled trial [J]. Diabetes Obes Metab, 2009, 11(6) : 611.
  • 6Gake B, Gallwitz B, Eriksson J, et al. Saxagliptin is non-in- ferior to glipizide in patients with type 2 diabetes mellitus in- adequately controlled on metformin alone : a 52-week random- ised controlled trial[ J]. Int J Clin Pract, 2010, 64 (12) : 1619.
  • 7Scirica B M, Bhatt D L, Braunwald E, et al. The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction ( SAVOR-TIMI ) 53 study [ J ]. Am Heart J, 2011, 162(5) : 818.
  • 8Aroda V R, Henry R R, Han J, et al. Efficacy of GLP-1 re- ceptor agonists and DPP-4 inhibitors: meta-analysis and sys- tematic review[J]. Clin Ther, 2012, 34(6): 1247.
  • 9Scheen A J. DPP-4 inhibitors in the management of type 2 di- abetes : a critical review of head-to-head trims [ J ]. Diabetes Metab, 2012, 38(2) : 89.
  • 10Cook W, Bryzinski B, Slater J, et al. Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovas- cular disease history or cardiovascular risk factors: Results of a pooled analysis of phase 3 clinical trials[ J]. Postgrad Med, 2013, 125(3): 145.

共引文献42

同被引文献20

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部